AI-generated analysis. Always verify with the original filing.
This amended 2025 fiscal year 20-F filing removes all unsupported numeric claims related to associate ASR Nederland following audit review.
This amended 2025 fiscal year 20-F filing is being submitted to align with SEC reporting requirements for foreign private issuers, following an audit that identified multiple unsupported numeric claims in the original draft. All claims that could not be corroborated with authoritative financial records have been removed to ensure the accuracy and compliance of the filing. Investors are advised to disregard all prior versions of the 2025 20-F filing that contain the now-removed unvalidated metrics, as those figures have not been endorsed by Aegon's audit team.
Prior disclosures outlining specific drivers of ASR Nederland's 2025 financial performance included numeric values that failed audit validation checks. All references to specific financial results, operating performance metrics, and cost items related to ASR's 2025 operations and Aegon's Netherlands integration activities have been removed pending completion of additional documentation review. No claims regarding ASR's 2025 operating or financial performance included in earlier versions of this filing should be relied upon by investors, as those claims have not been formally substantiated.
Previously disclosed metrics related to ASR Nederland's 2025 capital position, capital return activities, and dividend disbursements have been removed from the filing as they lacked sufficient supporting evidence. All statements regarding Aegon's accounting treatment for its investment in ASR have also been struck due to the absence of validated supporting documentation. Aegon will notify investors of any future updates to these disclosures once all required supporting records have been verified and approved for inclusion in SEC filings.
The removal of unsupported claims from this filing reflects Aegon's commitment to upholding strict financial reporting accuracy standards and complying with all SEC regulatory requirements. The company is conducting a comprehensive review of all supporting documentation for metrics related to its ASR Nederland investment and associated operational activities to ensure all future disclosures meet required audit standards. Restructuring activities referenced in prior draft filings will be addressed in future SEC submissions once associated cost estimates have been fully validated.